Paper19829367
Neuroscience: Alzheimer's disease.
Mucke L. Nature, 2009. Cited by 330 papers, by iCite.
Cite this record
ConductScience Library. Neuroscience: Alzheimer's disease. Papers, record 19829367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19829367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Age of Onset | |
| Aging | |
| Amyloid beta-Peptides | |
| Animals | |
| Controlled Clinical Trials as Topic | |
| Genetic Testing | |
| Humans | |
| Mice | |
| Stem Cell Transplantation | |
| Treatment Failure | |
| United States |
Source PubMed
References3
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16567625 | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16567625 | PubMed |
| 2 | 17082448 | 100 years and counting: prospects for defeating Alzheimer's disease. | Science | 2006 | https://conductscience.org/library/papers/17082448 | PubMed |
| 3 | 19426951 | 2009 Alzheimer's disease facts and figures. | Alzheimers Dement | 2009 | https://conductscience.org/library/papers/19426951 | PubMed |
Cited by201
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 330 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42547900 | Brain insulin resistance as a driver of proteinopathy in neurodegeneration: from cell-type-specific mechanisms to targeted therapeutics. | Transl Neurodegener | 2026 | https://conductscience.org/library/papers/42547900 | PubMed |
| 42389265 | Advances in the treatment of Alzheimer's disease. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42389265 | PubMed |
| 42325956 | ALDOC modulates astrocytic glycolysis and AMPK/mTOR/HIF-1α signaling in Alzheimer's disease. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42325956 | PubMed |
| 42228053 | Ultrasound-induced blood-brain barrier opening in Alzheimer's disease: a systematic review of clinical studies. | Aging Clin Exp Res | 2026 | https://conductscience.org/library/papers/42228053 | PubMed |
| 41909487 | Neurovascular dysfunction in the development and progression of neuroinflammatory diseases. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/41909487 | PubMed |
| 41541199 | Design and synthesis of new phosphazine and triazole derivatives for treatment of Alzheimer's disease: modulating ROS/JNK and Wnt/β-catenin signaling pathways. | RSC Adv | 2026 | https://conductscience.org/library/papers/41541199 | PubMed |
| 41526725 | Early prediction of Alzheimer's disease using longitudinal electronic health records of US military veterans. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/41526725 | PubMed |
| 41285799 | Single-nucleus and spatial transcriptomic profiling of human temporal cortex and white matter reveals key associations with AD pathology. | Nat Commun | 2025 | https://conductscience.org/library/papers/41285799 | PubMed |
| 40968863 | Rigid DNA Frameworks Anchored Transistor Enabled Ultrasensitive Detection of Aβ-42 in Serum. | Sensors (Basel) | 2025 | https://conductscience.org/library/papers/40968863 | PubMed |
| 40849361 | CARE-AD: a multi-agent large language model framework for Alzheimer's disease prediction using longitudinal clinical notes. | NPJ Digit Med | 2025 | https://conductscience.org/library/papers/40849361 | PubMed |
| 40753761 | The immune response within Alzheimer's disease: from the lense of peripheral monocyte-derived macrophages. | J Neuroimmunol | 2025 | https://conductscience.org/library/papers/40753761 | PubMed |
| 40635209 | Neuroprotective Effects of Eugenol in Alzheimer's Disease: Mitigating Oxidative Stress, Inflammation and Amyloid Plaques. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/40635209 | PubMed |
| 40546882 | Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions. | Ibrain | 2025 | https://conductscience.org/library/papers/40546882 | PubMed |
| 40544200 | Advance and Prospect of Positron Emission Tomography in Alzheimer's disease research. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/40544200 | PubMed |
| 40474028 | Bioactive compound nanoparticles for Alzheimer's disease. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40474028 | PubMed |
| 40461650 | Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles. | Sci Rep | 2025 | https://conductscience.org/library/papers/40461650 | PubMed |
| 40281748 | Multimodal Classification of Alzheimer's Disease Using Longitudinal Data Analysis and Hypergraph Regularized Multi-Task Feature Selection. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40281748 | PubMed |
| 40273133 | Amyloid β induces hormetic-like effects through major stress pathways in a C. elegans model of Alzheimer's Disease. | PLoS One | 2025 | https://conductscience.org/library/papers/40273133 | PubMed |
| 40234291 | Functionalized Nanoparticles: A Promising Approach for Effective Management of Alzheimer's Disease. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40234291 | PubMed |
| 40220245 | Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40220245 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19829367
GET https://conductscience.org/api/papers/v1/19829367/cited_by?page=2